Validation of Laboratory-Developed Molecular Assays for Infectious Diseases

Clinical Microbiology Reviews - Tập 23 Số 3 - Trang 550-576 - 2010
Eileen M. Burd1
1Emory University Hospital, Atlanta, Georgia

Tóm tắt

SUMMARY Molecular technology has changed the way that clinical laboratories diagnose and manage many infectious diseases. Excellent sensitivity, specificity, and speed have made molecular assays an attractive alternative to culture or enzyme immunoassay methods. Many molecular assays are commercially available and FDA approved. Others, especially those that test for less common analytes, are often laboratory developed. Laboratories also often modify FDA-approved assays to include different extraction systems or additional specimen types. The Clinical Laboratory Improvement Amendments (CLIA) federal regulatory standards require clinical laboratories to establish and document their own performance specifications for laboratory-developed tests to ensure accurate and precise results prior to implementation of the test. The performance characteristics that must be established include accuracy, precision, reportable range, reference interval, analytical sensitivity, and analytical specificity. Clinical laboratories are challenged to understand the requirements and determine the types of experiments and analyses necessary to meet the requirements. A variety of protocols and guidelines are available in various texts and documents. Many of the guidelines are general and more appropriate for assays in chemistry sections of the laboratory but are applied in principle to molecular assays. This review presents information that laboratories may consider in their efforts to meet regulatory requirements.

Từ khóa


Tài liệu tham khảo

10.1016/j.mcp.2008.06.001

10.1006/mcpr.1996.0022

10.1016/S0140-6736(86)90837-8

Bolotin, S., C. De Lima, K. W. Choi, E. Lombos, L. Burton, T. Mazzulli, and S. J. Drews. 2009. Validation of the TaqMan Influenza A Detection Kit and a rapid automated total nucleic acid extraction method to detect influenza A virus in nasopharyngeal specimens. Ann. Clin. Lab. Sci.39:155-159.

10.1016/j.jcv.2007.11.025

Statistical quality control for quantitative measurement procedures: principles and definitions. 2006

Defining establishing and verifying reference intervals in the clinical laboratory. 2008

Evaluation of precision performance of quantitative measurement methods. 2004

Evaluation of the linearity of quantitative measurement procedures: a statistical approach. 2003

Interference testing in clinical chemistry. 2005

Method comparison and bias estimation using patient samples. 2002

User protocol for evaluation of qualitative test performance. 2008

Evaluation of matrix effects. 2005

User verification of performance for precision and trueness. 2005

Protocols for determination for limits of detection and limits of quantitation. 2004

Molecular diagnostic methods for infectious diseases. 2006

Quantitative molecular methods for infectious diseases. 2003

Collection transport preparation and storage of specimens for molecular methods. 2005

Verification and validation of multiplex nucleic acid assays. 2008

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 21. Food and drugs 2010 vol. 8

Title 42. Public health 2009 vol. 4

Title 42. Public health 2009 vol. 4

Title 42. Public health 2009 vol. 4

Title 42. Public health 2009 vol. 4

Title 42. Public health 2009 vol. 4

Title 42. Public health 2009 vol. 4

Microbiology checklist. 2009

Molecular pathology checklist. 2009

10.1128/JCM.43.9.4551-4557.2005

10.1128/JCM.00443-06

10.1128/JCM.39.12.4302-4308.2001

10.1373/clinchem.2006.066498

10.1038/90290

10.1128/CMR.19.1.165-256.2006

Section 201(h) now codified as Title 21 food and drugs chapter 9 Federal Food Drug and Cosmetic Act subchapter II definitions section 321(h)

Molecular pathology in clinical practice Springer Science+Business Media 2007

FDA guidance for industry: bioanalytical method validation. 2001

10.1016/j.jviromet.2005.03.001

Probability and general statistical terms. 2006

International vocabulary of basic and general terms in metrology. 1993

Medical laboratories—particular requirements for quality and competence. 2007

Metrological traceability of values assigned to calibrators and control materials. 2003

10.5858/133.5.743

Johnson, R. 2008. Assessment of bias with emphasis on medical comparison. Clin. Biochem. Rev.29:S37-S42.

10.1186/1471-2180-6-2

Tietz textbook of clinical chemistry 1999

10.1016/j.jviromet.2008.07.014

10.1128/JCM.01303-06

10.1093/clinchem/45.6.882

Tietz textbook of clinical chemistry 2006

10.1111/j.1574-695X.2006.00125.x

10.1128/JCM.42.4.1471-1476.2004

10.1016/j.jviromet.2007.01.013

10.1373/clinchem.2005.060335

10.1128/JCM.42.5.1940-1946.2004

10.1186/1471-2180-8-77

10.7326/0003-4819-126-1-199701010-00026

Saldanha, J. 1993. Assays for viral sequences and their value in validation of viral elimination. Dev. Biol. Stand.81:231-236.

10.1016/j.clinmicnews.2007.05.002

Section 1862(a) (1) exclusions from coverage and Medicare as a second payer now codified as Title 42 chapter 7 exclusions from coverage and Medicare as a second payer

10.1373/clinchem.2006.070987

10.1002/jmv.2175

10.1351/pac200274050835

Reference deleted.

U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. 1992. Clinical laboratory improvement amendments of 1988 (CLIA). Fed. Regist.57:7002-7186.

U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. 2003. Medicare, Medicaid and CLIA programs: laboratory requirements relating to quality systems and certain personnel qualifications. Final rule. Fed. Regist.16:3640-3714.

10.1093/ajcp/93.2.252

Valle, L., D. Amicizia, S. Bacilieri, F. Banfi, R. Riente, P. Durando, L. Sticchi, R. Gasparini, C. Esposito, G. Icardi, and F. Ansaldi. 2006. Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus. J. Prev. Med. Hyg.47:127-133.

10.1128/JCM.00024-06

Basic QC practices 2002

Basic method validation 2008

10.3201/eid1307.070068

Glossary of terms for biological substances used for texts of the requirements. 1995

10.1373/clinchem.2005.051235

10.1016/j.jviromet.2005.06.015